Kapusta Matthew C 4
4 · uniQure N.V. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
uniQure (QURE) CEO Matthew Kapusta Exercises Options, Sells Shares
What Happened
- Matthew C. Kapusta, CEO and Managing Director of uniQure (QURE), exercised stock options and sold shares on June 24–25, 2026. He exercised a total of 32,844 shares at an exercise price of $31.71 (total exercise cost $1,041,483) and sold a total of 35,412 shares in open-market transactions for aggregate proceeds of about $1,771,174.
- The sales were executed at weighted-average prices of about $50.00–$50.02 (range reported $50.00–$50.30 for some trades). The filing also records the related disposition of the derivative instruments (options) on the exercise dates.
Key Details
- Transaction dates: June 24, 2026 and June 25, 2026; Form 4 filed June 26, 2026 (timely).
- Options exercised: 4,128 shares (6/24) and 28,716 shares (6/25) at $31.71 per share (reporting shows exercise cost totals of $130,899 and $910,584).
- Shares sold: 6,696 shares on 6/24 at a weighted average of $50.00 (proceeds $334,800) and 28,716 shares on 6/25 at $50.02 (proceeds $1,436,374). Total sale proceeds ≈ $1,771,174.
- Footnotes: Sales executed pursuant to a 10b5-1 trading plan adopted Oct 5, 2025 (F1). The 6/24 sale price reported is a weighted average across multiple trades in the $50.00–$50.30 range (F2). The stock option vested in full on Jan 25, 2023 (F3).
- Shares owned after the transactions: not disclosed in this filing.
Context
- This filing shows an option exercise followed by immediate open-market sales of the resulting shares, consistent with a sell-under-plan or cashless exercise pattern. The 10b5-1 plan note indicates the sales were pre-arranged to comply with insider trading rules.
- These are routine executive transactions to monetize vested options; filings are factual records and do not on their own indicate company performance or insider sentiment.
Insider Transaction Report
Form 4
uniQure N.V.QURE
Kapusta Matthew C
DirectorCEO, Managing Director
Transactions
- Exercise/Conversion
Ordinary Shares
[F1]2026-06-24$31.71/sh+4,128$130,899→ 525,923 total - Sale
Ordinary Shares
[F1]2026-06-24$50.00/sh−6,696$334,800→ 519,227 total - Exercise/Conversion
Ordinary Shares
[F1]2026-06-25$31.71/sh+28,716$910,584→ 547,943 total - Sale
Ordinary Shares
[F1][F2]2026-06-25$50.02/sh−28,716$1,436,374→ 519,227 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-06-24−4,128→ 74,578 totalExercise: $31.71Exp: 2029-01-25→ Ordinary Shares (4,128 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-06-25−28,716→ 45,862 totalExercise: $31.71Exp: 2029-01-25→ Ordinary Shares (28,716 underlying)
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Stock Option vested in full on January 25, 2023.
Signature
/s/ Christian Klemt, Attorney-in-Fact|2026-06-26